PortViewPortView
Bruker logo

Bruker (BRKRP) Stock Analysis

NASDAQHealthcareMedical - Devices

$435.95+5.01%
1-year price historyRange $250.50 – $474.99
52-week range$435.95
$250.00$474.99

What Bruker does

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Key metrics

Market cap
$8.75B
P/E (TTM)
236.93
EPS (TTM)
$1.84
Beta
1.39
Dividend yield
0.34%
Revenue / share
$22.99
50-day avg
$435.25
200-day avg
$365.41
52-week high
$474.99
52-week low
$250.00
CEO
Frank H. Laukien

ETFs linked to BRKRP

Broad-market and Healthcare sector ETFs an investor holding Bruker is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BRKRP fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze BRKRP in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Bruker?
Bruker trades under the ticker BRKRP on NASDAQ.
Which exchange is BRKRP listed on?
BRKRP is listed on NASDAQ.
What sector does Bruker operate in?
Bruker is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze BRKRP in a portfolio?
PortView shows BRKRP's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.